Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2659

Actual shortage: 251 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2399 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

27 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2020-02-21 2020-05-08 106955
ACT LATANOPROST/TIMOLOL 5MG 50MCG SOLUTION Resolved 2020-03-06 2020-03-26 108027
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2020-03-12 2020-08-27 108601
TEVA-SALBUTAMOL STERINEBS P.F. 2MG SOLUTION Resolved 2020-03-26 2020-05-29 109626
TEVA-FULVESTRANT INJECTION 50MG SOLUTION Resolved 2020-04-02 2020-05-01 110691
TEVA-COMBO STERINEBS 0.5MG 2.5MG SOLUTION Resolved 2020-04-02 2020-07-30 110706
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2020-04-23 2020-08-27 113031
TEVA-IPRATROPIUM STERINEBS 250MCG SOLUTION Resolved 2020-05-01 2020-05-14 113764
CINQAIR 10MG SOLUTION Resolved 2020-05-08 2020-09-03 114421
TRISENOX 10MG SOLUTION Actual shortage 2020-05-14 2022-06-03 115216
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Resolved 2020-05-29 2020-06-04 116159
ZOLEDRONIC ACID FOR INJECTION 4MG SOLUTION Resolved 2020-06-11 2023-10-03 117593
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-06-18 2020-06-25 118253
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2020-08-06 2020-11-07 121865
TEVA-SALBUTAMOL STERINEBS P.F. 2MG SOLUTION Resolved 2020-09-03 2020-09-17 123735
ACT LATANOPROST/TIMOLOL 50MCG 5MG SOLUTION Resolved 2020-09-11 2020-12-17 124101
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Resolved 2020-10-01 2021-01-07 125497
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2020-10-15 2020-11-26 126533
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-10-22 2020-11-12 126918
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2020-11-06 2021-01-07 128028

Showing 741 to 760 of 2659

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623

Showing 1 to 20 of 250